Why Is Phreesia Stock Sinking Tuesday?

Phreesia Sees Weaker Pharma Spending VisibilityPhreesia on Monday lowered its fiscal 2027 revenue outlook to $510–$520 million, down from $545–$559 million, citing reduced visibility into pharma client spending and weaker-than-expected commitments for the second half of the year.Some clients are allocating fewer dollars due to brand-specific factors, including regulatory impacts.Management does not view this as a structural demand shift but flagged increased variability in network solutions revenue, particu ...